Stay updated on Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial page
- Check7 days agoChange DetectedThe revision label on the history page changed from v3.6.2 to v3.6.3, indicating a new internal release. This update does not alter any study information or user-facing content.SummaryDifference0.0%

- Check14 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2 in the Record History view, indicating a software/UI update to the study record page. This update reflects a newer page version rather than changes to study data.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe history now shows that recruitment has ceased for the study and adds Revision: v3.6.0, while removing Revision: v3.5.5, reflecting an update to the documentation and versioning.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a behind-the-scenes update rather than edits to trial content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe revision label on the page changes from v3.5.3 to v3.5.4, indicating a new revision of the page. This reflects a minor update to the page's software or metadata rather than substantive trial information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe history now shows Revision: v3.5.3 as the latest version, replacing the previous v3.5.2. This update reflects a metadata/version change to the study record rather than any substantive changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Insulin Icodec and Glargine in Type 2 Diabetes Clinical Trial page.